Shefali Agarwal Insider Profile
11 Followers
Shefali Agarwal, Director at Fate Therapeutics, holds 0.00 shares in Epizyme (Ticker: EPZM), holds 10.49K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in Gritstone bio (Ticker: GRTSQ).
Shefali Agarwal's Trading History
| EPZMEpizyme | Aug 16, 2022 | ― | Uninformative Sell | ― | $0.00 | |
| FATEFate Therapeutics | Jun 13, 2022 | Director | Uninformative Buy | ― | $13.43K | |
| GRTSQGritstone bio | ― | ― | ― | ― |
You May Also Like
Shefali Agarwal insider profile FAQ
What is the percentage of profitable transactions made by Shefali Agarwal?
The percentage of profitable transactions made by Shefali Agarwal is 100%.
What is the average return per transaction made by Shefali Agarwal?
The average return per transaction made by Shefali Agarwal is 76.50%.
What stocks does Shefali Agarwal hold?
Shefali Agarwal holds: FATE, EPZM, GRTSQ stocks.
What was Shefali Agarwal's most profitable transaction?
Shefali Agarwal’s most profitable transaction was an Informative Sell of FATE stock on June 8, 2022. The return on the trade was 78.10%.
What is Shefali Agarwal's role in Fate Therapeutics?
Shefali Agarwal's role in Fate Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
